A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting
Clinical trial NCT03021018 · COMPLETED
Trial details
- NCT number
- NCT03021018
- Sponsor
- UCB Biopharma S.P.R.L.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-06
- Primary completion
- 2018-04-27
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.